Article Information
History
- July 14, 2022.
Article Versions
- Version 1 (July 12, 2022 - 14:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Lijie Kong1,2,*,
- Chaojie Ye1,2,*,
- Yiying Wang1,2,
- Jie Zheng3,
- Shuangyuan Wang1,2,
- Hong Lin1,2,
- Zhiyun Zhao1,2,
- Mian Li1,2,
- Yu Xu1,2,
- Jieli Lu1,2,
- Yuhong Chen1,2,
- Min Xu1,2,
- Weiqing Wang1,2,
- Guang Ning1,2,
- Yufang Bi1,2 and
- Tiange Wang1,2,†
- 1Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- 2Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- 3MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom
- ↵†Correspondence: Tiange Wang
, MD, PhD. Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rujin 2nd Road, Shanghai, China. E-mail: wtg{at}live.cn. Phone number: 86-021-64370045.
↵* Lijie Kong and Chaojie Ye contributed equally as first authors.